Compare PTRN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTRN | HAE |
|---|---|---|
| Founded | 2013 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | N/A | 1996 |
| Metric | PTRN | HAE |
|---|---|---|
| Price | $17.75 | $56.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $19.56 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.1M | 760.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.54 |
| EPS | N/A | ★ 2.46 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $27.89 | N/A |
| Revenue Next Year | $22.19 | $5.23 |
| P/E Ratio | ★ N/A | $23.23 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.19 | $47.32 |
| 52 Week High | $20.10 | $87.32 |
| Indicator | PTRN | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 75.36 | 48.77 |
| Support Level | $15.81 | $54.92 |
| Resistance Level | $18.95 | $62.48 |
| Average True Range (ATR) | 0.92 | 3.09 |
| MACD | 0.23 | 0.20 |
| Stochastic Oscillator | 90.67 | 61.06 |
Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.